BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1022 related articles for article (PubMed ID: 22399170)

  • 1. [Anti-candidal activity of clinical Pseudomonas aeruginosa strains and in vitro inhibition of Candida biofilm formation].
    Keçeli Özcan S; Dündar D; Sönmez Tamer G
    Mikrobiyol Bul; 2012 Jan; 46(1):39-46. PubMed ID: 22399170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticandidal activity of Pseudomonas aeruginosa strains isolated from clinical specimens.
    Kaleli I; Cevahir N; Demir M; Yildirim U; Sahin R
    Mycoses; 2007 Jan; 50(1):74-8. PubMed ID: 17302753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudomonas aeruginosa inhibits in-vitro Candida biofilm development.
    Bandara HM; Yau JY; Watt RM; Jin LJ; Samaranayake LP
    BMC Microbiol; 2010 Apr; 10():125. PubMed ID: 20416106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of Candida albicans with other Candida spp. and bacteria in the biofilms.
    El-Azizi MA; Starks SE; Khardori N
    J Appl Microbiol; 2004; 96(5):1067-73. PubMed ID: 15078523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of silver nanoparticles and nystatin on mixed biofilms of Candida glabrata and Candida albicans on acrylic.
    Silva S; Pires P; Monteiro DR; Negri M; Gorup LF; Camargo ER; Barbosa DB; Oliveira R; Williams DW; Henriques M; Azeredo J
    Med Mycol; 2013 Feb; 51(2):178-84. PubMed ID: 22803822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the ability of C. albicans to form biofilm in the presence of phage-resistant phenotypes of P. aeruginosa.
    Pires DP; Silva S; Almeida C; Henriques M; Anderson EM; Lam JS; Sillankorva S; Azeredo J
    Biofouling; 2013; 29(10):1169-80. PubMed ID: 24063626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudomonas aeruginosa lipopolysaccharide inhibits Candida albicans hyphae formation and alters gene expression during biofilm development.
    Bandara HM; K Cheung BP; Watt RM; Jin LJ; Samaranayake LP
    Mol Oral Microbiol; 2013 Feb; 28(1):54-69. PubMed ID: 23194472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biofilm formation of Candida albicans is variably affected by saliva and dietary sugars.
    Jin Y; Samaranayake LP; Samaranayake Y; Yip HK
    Arch Oral Biol; 2004 Oct; 49(10):789-98. PubMed ID: 15308423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Investigation of antifungal susceptibilities and some virulence factors of Candida strains isolated from blood cultures and genotyping by RAPD-PCR].
    Gültekin B; Eyigör M; Tiryaki Y; Kırdar S; Aydın N
    Mikrobiyol Bul; 2011 Apr; 45(2):306-17. PubMed ID: 21644074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candida albicans and Pseudomonas aeruginosa adhesion on soft contact lenses.
    Onurdağ FK; Ozkan S; Ozgen S; Olmuş H; Abbasoğlu U
    Graefes Arch Clin Exp Ophthalmol; 2011 Apr; 249(4):559-64. PubMed ID: 21170546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudomonas-Candida interactions: an ecological role for virulence factors.
    Hogan DA; Kolter R
    Science; 2002 Jun; 296(5576):2229-32. PubMed ID: 12077418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial lipopolysaccharides variably modulate in vitro biofilm formation of Candida species.
    Bandara HMHN; Lam OLT; Watt RM; Jin LJ; Samaranayake LP
    J Med Microbiol; 2010 Oct; 59(Pt 10):1225-1234. PubMed ID: 20576747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro biofilm formation and relationship with antifungal resistance of Candida spp. isolated from vaginal and intrauterine device string samples of women with vaginal complaints].
    Calışkan S; Keçeli Özcan S; Cınar S; Corakçı A; Calışkan E
    Mikrobiyol Bul; 2011 Oct; 45(4):697-706. PubMed ID: 22090300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of oral bacteria on growth and survival of Candida albicans biofilms.
    Thein ZM; Samaranayake YH; Samaranayake LP
    Arch Oral Biol; 2006 Aug; 51(8):672-80. PubMed ID: 16620775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candida/Candida biofilms. First description of dual-species Candida albicans/C. rugosa biofilm.
    Martins CHG; Pires RH; Cunha AO; Pereira CAM; Singulani JL; Abrão F; Moraes T; Mendes-Giannini MJS
    Fungal Biol; 2016 Apr; 120(4):530-537. PubMed ID: 27020154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed biofilms formed by C. albicans and non-albicans species: a study of microbial interactions.
    Santos JD; Piva E; Vilela SF; Jorge AO; Junqueira JC
    Braz Oral Res; 2016; 30():. PubMed ID: 26981754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro biofilm formation of Candida albicans and non-albicans Candida species under dynamic and anaerobic conditions.
    Thein ZM; Samaranayake YH; Samaranayake LP
    Arch Oral Biol; 2007 Aug; 52(8):761-7. PubMed ID: 17321487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both Pseudomonas aeruginosa and Candida albicans Accumulate Greater Biomass in Dual-Species Biofilms under Flow.
    Kasetty S; Mould DL; Hogan DA; Nadell CD
    mSphere; 2021 Jun; 6(3):e0041621. PubMed ID: 34160236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biofilm production and antifungal susceptibility patterns of Candida species].
    Yücesoy M; Karaman M
    Mikrobiyol Bul; 2004; 38(1-2):91-8. PubMed ID: 15293907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of biofilm formation in clinical isolates of Candida species causing bloodstream infection.
    Pannanusorn S; Fernandez V; Römling U
    Mycoses; 2013 May; 56(3):264-72. PubMed ID: 23113805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.